The hypothermic response to bacterial lipopolysaccharide critically depends on brain CB1, but not CB2 or TRPV1, receptors

Journal of Physiology

Volumn 589, Issue 9, 2011, Pages 2415-2431

  Steiner, Alexandre A ^a,b   Molchanova, Alla Y ^a,c   Dogan, M Devrim ^a   Patel, Shreya ^a   Pétervári, Erika ^d   Balaskó, Márta ^d   Wanner, Samuel P ^a   Eales, Justin ^a   Oliveira, Daniela L ^a   Gavva, Narender R ^e   Almeida, M Camila ^a   Székely, Miklós ^a,d   Romanovsky, Andrej A ^a  

^a ST JOSEPH'S HOSPITAL AND MEDICAL CENTER   (United States)

^b ALBANY COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

^c INSTITUTE OF PHYSIOLOGY   (Belarus)

^d UNIVERSITY OF PÉCS   (Hungary)

^e AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; ANANDAMIDE; BACTERIUM LIPOPOLYSACCHARIDE; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CAPSAZEPINE; IBIPINABANT; RESINIFERATOXIN; RIMONABANT; TUMOR NECROSIS FACTOR ALPHA; VANILLOID RECEPTOR 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY TEMPERATURE; CONTROLLED STUDY; DESENSITIZATION; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL TEMPERATURE; EVOKED RESPONSE; FEMALE; HYPOTHERMIA; INFLAMMATION; MALE; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN TARGETING; RAT; RECEPTOR BLOCKING; SYSTEMIC DISEASE; THERMODYNAMICS;

ANALYSIS OF VARIANCE; ANIMALS; ARACHIDONIC ACIDS; BODY TEMPERATURE REGULATION; BORNANES; BRAIN; CAPSAICIN; DISEASE MODELS, ANIMAL; DITERPENES; FEMALE; HYPOTHERMIA; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENOUS; INJECTIONS, INTRAVENTRICULAR; LIPOPOLYSACCHARIDES; MALE; PIPERIDINES; POLYUNSATURATED ALKAMIDES; PYRAZOLES; RATS; RATS, LONG-EVANS; RATS, WISTAR; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2; SIGNAL TRANSDUCTION; SULFONAMIDES; TIME FACTORS; TRPV CATION CHANNELS;

EID: 79955393912     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2010.202465     Document Type: Article

References (115)

1. Abercrombie ED & Jacobs BL (1987). Single-unit response of noradrenergic neurons in the locus coeruleus of freely moving cats. II. Adaptation to chronically presented stressful stimuli. J Neurosci 7, 2844-2848.
2. Almeida MC, Steiner AA, Branco LG & Romanovsky AA (2006a). Cold-seeking behavior as a thermoregulatory strategy in systemic inflammation. Eur J Neurosci 23, 3359-3367.
3. Almeida MC, Steiner AA, Branco LG & Romanovsky AA (2006b). Neural substrate of cold-seeking behavior in endotoxin shock. PLoS One 1, e1.
4. Arnold JC, Topple AN, Mallet PE, Hunt GE & McGregor IS (2001). The distribution of cannabinoid-induced Fos expression in rat brain: differences between the Lewis and Wistar strain. Brain Res 921, 240-255.
5. Arons MM, Wheeler AP, Bernard GR, Christman BW, Russell JA, Schein R, Summer WR, Steinberg KP, Fulkerson W, Wright P, Dupont WD & Swindell BB (1999). Effects of ibuprofen on the physiology and survival of hypothermic sepsis. Crit Care Med 27, 699-707.
6. Benamar K, Yondorf M, Meissler JJ, Geller EB, Tallarida RJ, Eisenstein TK & Adler MW (2007). A novel role of cannabinoids: implication in the fever induced by bacterial lipopolysaccharide. J Pharmacol Exp Ther 320, 1127-1133.
7. 9-tetrahydrocannabinol on cytokine and arachidonate release by mononuclear cells. Eur J Pharmacol 330, 231-240.
8. Blatteis CM (2006). Endotoxic fever: new concepts of its regulation suggest new approaches to its management. Pharmacol Ther 111, 194-223.
9. Borovikova LV, Ivanova S, Zhang M, Yang H, Botchkina GI, Watkins LR, Wang H, Abumrad N, Eaton JW & Tracey KJ (2000). Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405, 458-462.
10. Bouaboula M, Perrachon S, Milligan L, Canat X, Rinaldi-Carmona M, Portier M, Barth F, Calandra B, Pecceu F, Lupker J, Maffrand JP, Le Fur G & Casellas P (1997). A selective inverse agonist for central cannabinoid receptor inhibits mitogen-activated protein kinase activation stimulated by insulin or insulin-like growth factor 1. Evidence for a new model of receptor/ligand interactions. J Biol Chem 272, 22330-22339.
11. Bouaboula M, Rinaldi M, Carayon P, Carillon C, Delpech B, Shire D, Le Fur G & Casellas P (1993). Cannabinoid-receptor expression in human leukocytes. Eur J Biochem 214, 173-180.
12. Burston JJ, Sim-Selley LJ, Harloe JP, Mahadevan A, Razdan RK, Selley DE & Wiley JL (2008). N-Arachidonyl maleimide potentiates the pharmacological and biochemical effects of the endocannabinoid 2-arachidonylglycerol through inhibition of monoacylglycerol lipase. J Pharmacol Exp Ther 327, 546-553.
13. Cencioni MT, Chiurchiu V, Catanzaro G, Borsellino G, Bernardi G, Battistini L & Maccarrone M (2010). Anandamide suppresses proliferation and cytokine release from primary human T-lymphocytes mainly via CB2 receptors. PLoS One 5, e8688.
14. Chaperon F & Thiebot MH (1999). Behavioral effects of cannabinoid agents in animals. Crit Rev Neurobiol 13, 243-281.
15. Chiba T & Murata Y (1985). Afferent and efferent connections of the medial preoptic area in the rat: a WGA-HRP study. Brain Res Bull 14, 261-272.
16. Clemmer TP, Fisher CJ Jr, Bone RC, Slotman GJ, Metz CA & Thomas FO (1992). Hypothermia in the sepsis syndrome and clinical outcome. Crit Care Med 20, 1395-1401.
17. Crawley JN, Corwin RL, Robinson JK, Felder CC, Devane WA & Axelrod J (1993). Anandamide, an endogenous ligand of the cannabinoid receptor, induces hypomotility and hypothermia in vivo in rodents. Pharmacol Biochem Behav 46, 967-972.
18. Croci T, Landi M, Galzin AM & Marini P (2003). Role of cannabinoid CB1 receptors and tumor necrosis factor-α in the gut and systemic anti-inflammatory activity of SR 141716 (rimonabant) in rodents. Br J Pharmacol 140, 115-122.
19. De Laurentiis A, Fernandez-Solari J, Mohn C, Burdet B, Zubilete MA & Rettori V (2010). The hypothalamic endocannabinoid system participates in the secretion of oxytocin and tumor necrosis factor-α induced by lipopolysaccharide. J Neuroimmunol 221, 32-41.
20. Derbenev AV, Stuart TC & Smith BN (2004). Cannabinoids suppress synaptic input to neurones of the rat dorsal motor nucleus of the vagus nerve. J Physiol 559, 923-938.
21. Dhaka A, Viswanath V & Patapoutian A (2006). TRP ion channels and temperature sensation. Annu Rev Neurosci 29, 135-161.
22. Di Marzo V, Breivogel C, Bisogno T, Melck D, Patrick G, Tao Q, Szallasi A, Razdan RK & Martin BR (2000). Neurobehavioral activity in mice of N-vanillyl-arachidonyl-amide. Eur J Pharmacol 406, 363-374.
23. Dogan MD, Patel S, Rudaya AY, Steiner AA, Szekely M & Romanovsky AA (2004). Lipopolysaccharide fever is initiated via a capsaicin-sensitive mechanism independent of the subtype-1 vanilloid receptor. Br J Pharmacol 143, 1023-1032.
24. 2 receptors. J Neuroimmunol 189, 17-22.
25. Engblom D, Ek M, Saha S, Ericsson-Dahlstrand A, Jakobsson PJ & Blomqvist A (2002). Prostaglandins as inflammatory messengers across the blood-brain barrier. J Mol Med 80, 5-15.
26. Ephgrave K, Kremer T, Broadhurst K & Cullen J (1997). The role of platelet-activating factor in conscious, normotensive endotoxemia. J Surg Res 68, 170-174.
27. Farhang B, Diaz S, Tang SL & Wagner EJ (2009). Sex differences in the cannabinoid regulation of energy homeostasis. Psychoneuroendocrinology 34(Suppl 1), S237-S246.
28. Fegley D, Gaetani S, Duranti A, Tontini A, Mor M, Tarzia G & Piomelli D (2005). Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation. J Pharmacol Exp Ther 313, 352-358.
29. Fegley D, Kathuria S, Mercier R, Li C, Goutopoulos A, Makriyannis A & Piomelli D (2004). Anandamide transport is independent of fatty-acid amide hydrolase activity and is blocked by the hydrolysis-resistant inhibitor AM1172. Proc Natl Acad Sci U S A 101, 8756-8761.
30. Feleder C, Perlik V & Blatteis CM (2007a). Preoptic nitric oxide attenuates endotoxic fever in guinea pigs by inhibiting the POA release of norepinephrine. Am J Physiol Regul Integr Comp Physiol 293, R1144-R1151.
31. Feleder C, Perlik V & Blatteis CM (2007b). Preoptic norepinephrine mediates the febrile response of guinea pigs to lipopolysaccharide. Am J Physiol Regul Integr Comp Physiol 293, R1135-R1143.
32. Fernandez-Solari J, Prestifilippo JP, Bornstein SR, McCann SM & Rettori V (2006). Participation of the endocannabinoid system in the effect of TNF-α on hypothalamic release of gonadotropin-releasing hormone. Ann N Y Acad Sci 1088, 238-250.
33. 9-tetrahydrocannabinol. Br J Pharmacol 75, 409-414.
34. Fraga D, Zanoni CI, Rae GA, Parada CA & Souza GE (2009). Endogenous cannabinoids induce fever through the activation of CB1 receptors. Br J Pharmacol 157, 1494-1501.
35. Freund TF, Katona I & Piomelli D (2003). Role of endogenous cannabinoids in synaptic signaling. Physiol Rev 83, 1017-1066.
36. Galiegue S, Mary S, Marchand J, Dussossoy D, Carriere D, Carayon P, Bouaboula M, Shire D, Le Fur G & Casellas P (1995). Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur J Biochem 232, 54-61.
37. Garami A, Pakai E, Oliveira DL, Steiner AA, Wanner SP, Almeida MC, Lesnikov VA, Gavva NR & Romanovsky AA (2011). Thermoregulatory phenotype of the Trpv1 knockout mouse: thermoeffector dysbalance with hyperkinesis. J Neurosci 31, 1721-1733.
38. Garami A, Shimansky YP, Pakai E, Oliveira DL, Gavva NR & Romanovsky AA (2010). Contributions of different modes of TRPV1 activation to TRPV1 antagonist-induced hyperthermia. J Neurosci 30, 1435-1440.
39. Gavva NR, Tamir R, Qu Y, Klionsky L, Zhang TJ, Immke D, Wang J, Zhu D, Vanderah TW, Porreca F, Doherty EM, Norman MH, Wild KD, Bannon AW, Louis JC & Treanor JJ (2005). AMG 9810 [(E)-3-(4-t-butylphenyl)-N-(2, 3-dihydrobenzo[b][1, 4] dioxin-6-yl)acrylamide], a novel vanilloid receptor 1 (TRPV1) antagonist with antihyperalgesic properties. J Pharmacol Exp Ther 313, 474-484.
40. Germain N, Boichot E, Advenier C, Berdyshev EV & Lagente V (2002). Effect of the cannabinoid receptor ligand, WIN 55, 212-2, on superoxide anion and TNF-α production by human mononuclear cells. Int Immunopharmacol 2, 537-543.
41. Gonsiorek W, Lunn C, Fan X, Narula S, Lundell D & Hipkin RW (2000). Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide. Mol Pharmacol 57, 1045-1050.
42. Gordon CJ (1993). Temperature Regulation in Laboratory Rodents. Cambridge University Press, Cambridge, UK
43. Gourine AV, Rudolph K, Korsak AS, Kubatko J, Tesfaigzi J, Kozak W & Kluger MJ (2001). Role of capsaicin-sensitive afferents in fever and cytokine responses during systemic and local inflammation in rats. Neuroimmunomodulation 9, 13-22.
44. Hashimoto K, Suemaru S, Takao T, Sugawara M, Makino S & Ota Z (1988). Corticotropin-releasing hormone and pituitary-adrenocortical responses in chronically stressed rats. Regul Pept 23, 117-126.
45. Herkenham M, Lynn AB, Johnson MR, Melvin LS, de Costa BR & Rice KC (1991). Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J Neurosci 11, 563-583.
46. Hirasawa M, Schwab Y, Natah S, Hillard CJ, Mackie K, Sharkey KA & Pittman QJ (2004). Dendritically released transmitters cooperate via autocrine and retrograde actions to inhibit afferent excitation in rat brain. J Physiol 559, 611-624.
47. Iida T, Shimizu I, Nealen ML, Campbell A & Caterina M (2005). Attenuated fever response in mice lacking TRPV1. Neurosci Lett 378, 28-33.
48. Ivanov AI, Kulchitsky VA & Romanovsky AA (2003a). Role for the cholecystokinin-A receptor in fever: a study of a mutant rat strain and a pharmacological analysis. J Physiol 547, 941-949.
49. Ivanov AI, Patel S, Kulchitsky VA & Romanovsky AA (2003b). Platelet-activating factor: a previously unrecognized mediator of fever. J Physiol 553, 221-228.
50. Ivanov AI & Romanovsky AA (2002). Fever responses of Zucker rats with and without fatty mutation of the leptin receptor. Am J Physiol Regul Integr Comp Physiol 282, R311-R316.
51. Kanizsai P, Garami A, Solymar M, Szolcsanyi J & Szelenyi Z (2009). Energetics of fasting heterothermia in TRPV1-KO and wild type mice. Physiol Behav 96, 149-154.
52. Kozak W, Conn CA, Klir JJ, Wong GH & Kluger MJ (1995). TNF soluble receptor and antiserum against TNF enhance lipopolysaccharide fever in mice. Am J Physiol Regul Integr Comp Physiol 269, R23-R29.
53. Kozak W, Kluger MJ, Kozak A, Wachulec M & Dokladny K (2000). Role of cytochrome P-450 in endogenous antipyresis. Am J Physiol Regul Integr Comp Physiol 279, R455-R460.
54. 2. Am J Physiol Regul Integr Comp Physiol 298, R1512-R1521.
55. 1 cannabinoid receptor antagonists. J Med Chem 47, 627-643.
56. Leon LR, White AA & Kluger MJ (1998). Role of IL-6 and TNF in thermoregulation and survival during sepsis in mice. Am J Physiol Regul Integr Comp Physiol 275, R269-R277.
57. Lichtman AH, Cook SA & Martin BR (1996). Investigation of brain sites mediating cannabinoid-induced antinociception in rats: evidence supporting periaqueductal gray involvement. J Pharmacol Exp Ther 276, 585-593.
58. Liu J, Batkai S, Pacher P, Harvey-White J, Wagner JA, Cravatt BF, Gao B & Kunos G (2003). Lipopolysaccharide induces anandamide synthesis in macrophages via CD14/MAPK/phosphoinositide 3-kinase/NF-κB independently of platelet-activating factor. J Biol Chem 278, 45034-45039.
59. Long JZ, Li W, Booker L, Burston JJ, Kinsey SG, Schlosburg JE, Pavon FJ, Serrano AM, Selley DE, Parsons LH, Lichtman AH & Cravatt BF (2009). Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects. Nat Chem Biol 5, 37-44.
60. Mailleux P & Vanderhaeghen JJ (1992). Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization histochemistry. Neuroscience 48, 655-668.
61. Matias I & Di Marzo V (2007). Endocannabinoids and the control of energy balance. Trends Endocrinol Metab 18, 27-37.
62. Matsuda LA, Bonner TI & Lolait SJ (1993). Localization of cannabinoid receptor mRNA in rat brain. J Comp Neurol 327, 535-550.
63. Matsumura K & Kobayashi S (2004). Signaling the brain in inflammation: the role of endothelial cells. Front Biosci 9, 2819-2826.
64. McIntyre P, McLatchie LM, Chambers A, Phillips E, Clarke M, Savidge J, Toms C, Peacock M, Shah K, Winter J, Weerasakera N, Webb M, Rang HP, Bevan S & James IF (2001). Pharmacological differences between the human and rat vanilloid receptor 1 (VR1). Br J Pharmacol 132, 1084-1094.
65. Melia KR, Ryabinin AE, Schroeder R, Bloom FE & Wilson MC (1994). Induction and habituation of immediate early gene expression in rat brain by acute and repeated restraint stress. J Neurosci 14, 5929-5938.
66. Miranda A, Nordstrom E, Mannem A, Smith C, Banerjee B & Sengupta JN (2007). The role of transient receptor potential vanilloid 1 in mechanical and chemical visceral hyperalgesia following experimental colitis. Neuroscience 148, 1021-1032.
67. Mouihate A, Chen X & Pittman QJ (1998). Interleukin-1β fever in rats: gender difference and estrous cycle influence. Am J Physiol Regul Integr Comp Physiol 275, R1450-R1454.
68. Munro S, Thomas KL & Abu-Shaar M (1993). Molecular characterization of a peripheral receptor for cannabinoids. Nature 365, 61-65.
69. Naidu PS, Kinsey SG, Guo TL, Cravatt BF & Lichtman AH (2010). Regulation of inflammatory pain by inhibition of fatty acid amide hydrolase. J Pharmacol Exp Ther 334, 182-190.
70. Need AB, Davis RJ, Alexander-Chacko JT, Eastwood B, Chernet E, Phebus LA, Sindelar DK & Nomikos GG (2006). The relationship of in vivo central CB1 receptor occupancy to changes in cortical monoamine release and feeding elicited by CB1 receptor antagonists in rats. Psychopharmacology (Berl) 184, 26-35.
71. Nikami H, Mahmoud ME, Shimizu Y, Shiina T, Hirayama H, Iwami M, Dosoky RM, Ahmed MM & Takewaki T (2008). Capsaicin pretreatment attenuates LPS-induced hypothermia through TRPV1-independent mechanisms in chicken. Life Sci 82, 1191-1195.
72. Oka S, Yanagimoto S, Ikeda S, Gokoh M, Kishimoto S, Waku K, Ishima Y & Sugiura T (2005). Evidence for the involvement of the cannabinoid CB2 receptor and its endogenous ligand 2-arachidonoylglycerol in 12-O-tetradecanoylphorbol-13-acetate-induced acute inflammation in mouse ear. J Biol Chem 280, 18488-18497.
73. Ovadia H, Wohlman A, Mechoulam R & Weidenfeld J (1995). Characterization of the hypothermic effect of the synthetic cannabinoid HU-210 in the rat. Relation to the adrenergic system and endogenous pyrogens. Neuropharmacology 34, 175-180.
74. Paul L, Fraifeld V & Kaplanski J (1999). Evidence supporting involvement of leukotrienes in LPS-induced hypothermia in mice. Am J Physiol Regul Integr Comp Physiol 276, R52-R58.
75. Paxinos G & Watson C (2004). The Rat Brain in Stereotaxic Coordinates. Academic Press, San Diego
76. Petervari E, Koncsecsko-Gaspar M, Balasko M & Szekely M (2003). Increased thermoregulatory responsiveness in cold adapted but not in hyperthyroid hypermetabolic rats. Acta Physiol Hung 90, 1-8.
77. Porter AC, Sauer JM, Knierman MD, Becker GW, Berna MJ, Bao J, Nomikos GG, Carter P, Bymaster FP, Leese AB & Felder CC (2002). Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor. J Pharmacol Exp Ther 301, 1020-1024.
78. Portier M, Rinaldi-Carmona M, Pecceu F, Combes T, Poinot-Chazel C, Calandra B, Barth F, le Fur G & Casellas P (1999). SR 144528, an antagonist for the peripheral cannabinoid receptor that behaves as an inverse agonist. J Pharmacol Exp Ther 288, 582-589.
79. Price TJ, Patwardhan A, Akopian AN, Hargreaves KM & Flores CM (2004). Modulation of trigeminal sensory neuron activity by the dual cannabinoid-vanilloid agonists anandamide, N-arachidonoyl-dopamine and arachidonyl-2-chloroethylamide. Br J Pharmacol 141, 1118-1130.
80. Rawls SM, Cabassa J, Geller EB & Adler MW (2002). CB1 receptors in the preoptic anterior hypothalamus regulate WIN 55212-2 [(4, 5-dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrrolo[3, 2, 1ij]quinolin-6-one]-induced hypothermia. J Pharmacol Exp Ther 301, 963-968.
81. Rinaldi-Carmona M, Barth F, Heaulme M, Shire D, Calandra B, Congy C, Martinez S, Maruani J, Neliat G, Caput D, Ferrara P, Soubrie P, Breliere JC & Le Fur G (1994). SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett 350, 240-244.
82. Rinaldi-Carmona M, Barth F, Millan J, Derocq JM, Casellas P, Congy C, Oustric D, Sarran M, Bouaboula M, Calandra B, Portier M, Shire D, Breliere JC & Le Fur GL (1998). SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor. J Pharmacol Exp Ther 284, 644-650.
83. Roche M, Kelly JP, O'Driscoll M & Finn DP (2008). Augmentation of endogenous cannabinoid tone modulates lipopolysaccharide-induced alterations in circulating cytokine levels in rats. Immunology 125, 263-271.
84. Romanovsky AA, Almeida MC, Aronoff DM, Ivanov AI, Konsman JP, Steiner AA & Turek VF (2005). Fever and hypothermia in systemic inflammation: recent discoveries and revisions. Front Biosci 10, 2193-2216.
85. Romanovsky AA, Almeida MC, Garami A, Steiner AA, Norman MH, Morrison SF, Nakamura K, Burmeister JJ & Nucci TB (2009). The transient receptor potential vanilloid-1 channel in thermoregulation: a thermosensor it is not. Pharmacol Rev 61, 228-261.
86. Romanovsky AA, Ivanov AI & Shimansky YP (2002). Selected contribution: Ambient temperature for experiments in rats: a new method for determining the zone of thermal neutrality. J Appl Physiol 92, 2667-2679.
87. Romanovsky AA, Kulchitsky VA, Akulich NV, Koulchitsky SV, Simons CT, Sessler DI & Gourine VN (1996a). First and second phases of biphasic fever: two sequential stages of the sickness syndrome? Am J Physiol Regul Integr Comp Physiol 271, R244-R253.
88. Romanovsky AA, Kulchitsky VA, Simons CT & Sugimoto N (1998a). Methodology of fever research: why are polyphasic fevers often thought to be biphasic? Am J Physiol Regul Integr Comp Physiol 275, R332-R338.
89. Romanovsky AA, Shido O, Sakurada S, Sugimoto N & Nagasaka T (1996b). Endotoxin shock: thermoregulatory mechanisms. Am J Physiol Regul Integr Comp Physiol 270, R693-R703.
90. Romanovsky AA, Simons CT & Kulchitsky VA (1998b). 'Biphasic' fevers often consist of more than two phases. Am J Physiol Regul Integr Comp Physiol 275, R323-R331.
91. Romanovsky AA, Simons CT, Szekely M & Kulchitsky VA (1997). The vagus nerve in the thermoregulatory response to systemic inflammation. Am J Physiol Regul Integr Comp Physiol 273, R407-R413.
92. Rosas-Ballina M, Ochani M, Parrish WR, Ochani K, Harris YT, Huston JM, Chavan S & Tracey KJ (2008). Splenic nerve is required for cholinergic antiinflammatory pathway control of TNF in endotoxemia. Proc Natl Acad Sci U S A 105, 11008-11013.
93. Rudaya AY, Steiner AA, Robbins JR, Dragic AS & Romanovsky AA (2005). Thermoregulatory responses to lipopolysaccharide in the mouse: dependence on the dose and ambient temperature. Am J Physiol Regul Integr Comp Physiol 289, R1244-R1252.
94. Sacerdote P, Massi P, Panerai AE & Parolaro D (2000). In vivo and in vitro treatment with the synthetic cannabinoid CP55, 940 decreases the in vitro migration of macrophages in the rat: involvement of both CB1 and CB2 receptors. J Neuroimmunol 109, 155-163.
95. Saper CB, Loewy AD, Swanson LW & Cowan WM (1976). Direct hypothalamo-autonomic connections. Brain Res 117, 305-312.
96. Smart D, Gunthorpe MJ, Jerman JC, Nasir S, Gray J, Muir AI, Chambers JK, Randall AD & Davis JB (2000). The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1). Br J Pharmacol 129, 227-230.
97. Smith GP, Jerome C & Norgren R (1985). Afferent axons in abdominal vagus mediate satiety effect of cholecystokinin in rats. Am J Physiol Regul Integr Comp Physiol 249, R638-R641.
98. Spencer SJ, Mouihate A, Galic MA & Pittman QJ (2008). Central and peripheral neuroimmune responses: hyporesponsiveness during pregnancy. J Physiol 586, 399-406.
99. Stamp JA & Herbert J (1999). Multiple immediate-early gene expression during physiological and endocrine adaptation to repeated stress. Neuroscience 94, 1313-1322.
100. Steiner AA, Chakravarty S, Robbins JR, Dragic AS, Pan J, Herkenham M & Romanovsky AA (2005). Thermoregulatory responses of rats to conventional preparations of lipopolysaccharide are caused by lipopolysaccharide per se - not by lipoprotein contaminants. Am J Physiol Regul Integr Comp Physiol 289, R348-R352.
101. Steiner AA, Dogan MD, Ivanov AI, Patel S, Rudaya AY, Jennings DH, Orchinik M, Pace TW, O'Connor KA, Watkins LR & Romanovsky AA (2004). A new function of the leptin receptor: mediation of the recovery from lipopolysaccharide-induced hypothermia. FASEB J 18, 1949-1951.
102. Steiner AA, Hunter JC, Phipps SM, Nucci TB, Oliveira DL, Roberts JL, Scheck AC, Simmons DL & Romanovsky AA (2009a). Cyclooxygenase-1 or -2 - which one mediates lipopolysaccharide-induced hypothermia? Am J Physiol Regul Integr Comp Physiol 297, R485-R494.
103. Steiner AA, Krall CM & Liu E (2009b). A reappraisal on the ability of leptin to induce fever. Physiol Behav 97, 430-436.
104. Steiner AA, Turek VF, Almeida MC, Burmeister JJ, Oliveira DL, Roberts JL, Bannon AW, Norman MH, Louis JC, Treanor JJ, Gavva NR & Romanovsky AA (2007). Nonthermal activation of transient receptor potential vanilloid-1 channels in abdominal viscera tonically inhibits autonomic cold-defense effectors. J Neurosci 27, 7459-7468.
105. 2 and cholecystokinin octapeptide. Brain Res 844, 157-163.
106. Szallasi A & Blumberg PM (1989). Resiniferatoxin, a phorbol-related diterpene, acts as an ultrapotent analog of capsaicin, the irritant constituent in red pepper. Neuroscience 30, 515-520.
107. Szekely M (1979). Nutritional state and endotoxin fever of newborn rabbits. Acta Physiol Acad Sci Hung 53, 279-283.
108. Szekely M & Szolcsanyi J (1979). Endotoxin fever in capsaicin treated rats. Acta Physiol Acad Sci Hung 53, 469-477.
109. Tollner B, Roth J, Storr B, Martin D, Voigt K & Zeisberger E (2000). The role of tumor necrosis factor (TNF) in the febrile and metabolic responses of rats to intraperitoneal injection of a high dose of lipopolysaccharide. Pflugers Arch 440, 925-932.
110. Tominaga M & Caterina MJ (2004). Thermosensation and pain. J Neurobiol 61, 3-12.
111. Villanueva A, Yilmaz SM, Millington WR, Cutrera RA, Stouffer DG, Parsons LH, Cheer JF & Feleder C (2009). Central cannabinoid 1 receptor antagonist administration prevents endotoxic hypotension affecting norepinephrine release in the preoptic anterior hypothalamic area. Shock 32, 614-620.
112. Vogel Z, Barg J, Levy R, Saya D, Heldman E & Mechoulam R (1993). Anandamide, a brain endogenous compound, interacts specifically with cannabinoid receptors and inhibits adenylate cyclase. J Neurochem 61, 352-355.
113. Waksman Y, Olson JM, Carlisle SJ & Cabral GA (1999). The central cannabinoid receptor (CB1) mediates inhibition of nitric oxide production by rat microglial cells. J Pharmacol Exp Ther 288, 1357-1366.
114. Walter L, Franklin A, Witting A, Wade C, Xie Y, Kunos G, Mackie K & Stella N (2003). Nonpsychotropic cannabinoid receptors regulate microglial cell migration. J Neurosci 23, 1398-1405.
115. Zygmunt PM, Petersson J, Andersson DA, Chuang H, Sorgard M, Di Marzo V, Julius D & Hogestatt ED (1999). Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 400, 452-457.